Ewa Karwatowska‐Prokopczuk
0000-0002-6371-5834
Publication & Citation Trends
Publications
0 total
APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia. OA
Cited by 38
Semantic Scholar
On-treatment platelet reactivity through the thromboxane A_2 or P2Y12 platelet receptor pathways is not affected by pelacarsen
Cited by 1
Semantic Scholar
Effect of APOC3 inhibition with volanesorsen on hepatic steatosis in patients with severe hypertriglyceridemia OA
Cited by 0
Semantic Scholar
Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by NMR in patients with hypertriglyceridemia. OA
Cited by 39
Semantic Scholar
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk OA
Cited by 45
Semantic Scholar
Efficacy and safety of pelacarsen in lowering Lp(a) in healthy Japanese subjects.
Cited by 29
Semantic Scholar
Assessment of the Effect of Organ Impairment on the Pharmacokinetics of 2′‐MOE and Phosphorothioate Modified Antisense Oligonucleotides
Cited by 5
Semantic Scholar
Research Topics
Lipid metabolism and disorders
(25)
Cardiac electrophysiology and arrhythmias
(24)
Cardiac Imaging and Diagnostics
(12)
Cardiac Ischemia and Reperfusion
(11)
Diabetes, Cardiovascular Risks, and Lipoproteins
(10)
Affiliations
Università Cattolica del Sacro Cuore
Scripps Research Institute
Western University
Brigham and Women's Hospital
San Francisco VA Medical Center